Voyager Therapeutics Inc (VYGR) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Voyager Therapeutics Inc   (NASDAQ: VYGR)


Voyager Therapeutics Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Voyager Therapeutics Inc 's ROA in the second quarter of 2026?
Voyager Therapeutics Inc recorded a cumulative net loss of $-108 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -40.06%.

However, within the Healthcare sector 527 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3836, from total ROA ranking in the first quarter of 2026 at 4445.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change -38.56 % -37.91 % -28.83 % -25.82 % 27.05 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -108 -117 -120 -127 -108
Return On Assets (TTM) -40.06 % -36.72 % -34.1 % -33.61 % -26.83 %
VYGR's Total Ranking # 3836 # 4445 # 3872 # 3759 # 3645
Total Assets (TTM) in million 311 219 258 288 505
Seq. Total Assets Change 41.6 % -14.83 % -10.68 % -42.96 % 43.09 %
Seq. Net Income Change - - - - -

VYGR's 5 Years Annual ROA >> Back to VYGR Management Effectiveness >> Compare VYGR ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 72
Sector # 528
Overall # 3829

Return On Assets Statistics
High Average Low
45.67 %
-16.44 %
-45 %
(Mar 31 2023)   (Jun 30 2026)





Financial Statements
Voyager Therapeutics Inc 's Assets $ 311 million VYGR's Balance sheet
Voyager Therapeutics Inc 's Income $ -24 million Quarterly VYGR's Income Statement
VYGR's Income by Division See VYGR's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -28.83 % 7.63 % 136.15 % -10.25 % -28.94 %
Total Assets in million 258 362 336 142 159
Y / Y Net Income Change - - - - -
Net Income in million -120 -65 132 -46 -71
Annual Return On Assets -46.49 % -17.96 % 39.36 % -32.6 % -44.89 %

VYGR's 5 Years Annual ROA >> Back to VYGR Management Effectiveness >> Compare VYGR ROA to its Competitors



More Return On Assets Ratios
VYGR's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
VYGR's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for VYGR's Competitors
Subscribers only: Roa for Voyager Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for VYGR's Customers

You may also want to know
VYGR's Roi VYGR's Inventory Turnover Ratio VYGR's Growth Rates VYGR's Dividend Comparisons
VYGR's Profitability Ratios VYGR's Asset Turnover Ratio VYGR's Dividend Growth
VYGR's Roe VYGR's Valuation Ratios VYGR's Financial Strength Ratios VYGR's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-08T21:47:13+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.